Gervacio, Baby Girl .
HRN: 27-27-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2025
AMPICILLIN 250MG (VIAL)
06/25/2025
07/01/2025
IV
150mg
Q12
T/C MAS
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes